Exploring Current Practice, Knowledge, and Challenges of Sexually Transmitted Infection/HIV Management and Pre-Exposure Prophylaxis Among Japanese Health Care Professionals: A Cross-Sectional Web Survey [0.03%]
探索日本医疗保健专业人员对性传播感染/艾滋病管理和暴露前预防的当前做法、知识和挑战：一项横断面网络调查
Mayuko Kamakura,Daisuke Fukuda,Naho Kuroishi et al.
Mayuko Kamakura et al.
We conducted a web-based survey targeting physicians in specialties of treating sexually transmitted infection (STI) and/or human immunodeficiency virus (HIV) patients to understand the current STI/HIV care practices and their acceptability...
HIV Pre-Exposure Prophylaxis Use on a Global Scale Among Men Who Have Sex with Men: A Systematic Review and Meta-Analysis [0.03%]
全球 MSM 中使用口服暴露前预防药物以防治 HIV 的系统评价和 meta 分析
Yiting Huang,Runmeng Tian,Ziwei Zhou et al.
Yiting Huang et al.
Knowledge of the proportion of Pre-Exposure Prophylaxis (PrEP) use among men who have sex with men (MSM) and the specific gaps in PrEP use can stimulate enhanced focus on HIV prevention policies and programs. To summarize the proportion of ...
Impact of COVID-19 on Sexually Transmitted Infection and HIV Screening at an Urban Safety-Net Hospital [0.03%]
新冠肺炎疫情对城市安全医院性传播感染和艾滋病筛查的影响
Tyler N Lescure,Jessica Stewart,Heather Sperring et al.
Tyler N Lescure et al.
HIV and other sexually transmitted infections (STIs) are on the rise nationally and internationally. The coronavirus 2019 (COVID-19) pandemic drove a shift toward telemedicine and prioritization of symptomatic treatment over asymptomatic sc...
Understanding Retention in the HIV Pre-Exposure Prophylaxis Cascade Among Cisgender Women [0.03%]
了解顺式女性HIV暴露前预防全程中的保留状况
Jamie A Burns,Shawnika J Hull,Aisha Inuwa et al.
Jamie A Burns et al.
HIV remains a significant public health concern in the United States, with 34,800 new cases diagnosed in 2019; of those, 18% were among women. Oral pre-exposure prophylaxis (PrEP) with daily tenofovir disoproxil fumarate/emtricitabine is ef...
Nadia Rehman,Michael Wu,Cristian Garcia et al.
Nadia Rehman et al.
People living with HIV (PLHIV) need lifelong medical care. However, retention in HIV care is not measured uniformly, making it challenging to compare or pool data. The objective of this study within a review (SWAR) is to describe the assort...
Awareness of and Willingness to Use On-Demand HIV Pre-Exposure Prophylaxis Among Gay, Bisexual, and Other Men Who Have Sex with Men Using a Gay Social Networking App in China [0.03%]
中国男同性恋社交网络平台用户对按需型暴露前预防措施的认知和使用意愿调查研究
Chenglin Hong,Ian W Holloway,Susan M Graham et al.
Chenglin Hong et al.
In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children [0.03%]
宫内暴露于抗逆转录病毒药物与HIV暴露未感染儿童五年时神经发育问题的风险的关系
Tzy-Jyun Yao,Kathleen Malee,Joel Zhang et al.
Tzy-Jyun Yao et al.
Studies have observed neurodevelopmental (ND) challenges among young children perinatally HIV-exposed yet uninfected (CHEU) with in utero antiretroviral (ARV) exposure, without clear linkage to specific ARVs. Atazanavir (ATV) boosted with r...
High Prevalence of Asymptomatic Sexually Transmitted Infections in Austrian Pre-Exposure Prophylaxis Users: A Prospective Observational Study [0.03%]
奥地利暴露前预防用药者中无症状性性传播感染高发的前瞻性观察研究
David Chromy,Nikolaus Urban,Katharina Grabmeier-Pfistershammer et al.
David Chromy et al.
Observational Study
AIDS patient care and STDs. 2023 Mar;37(3):115-118. DOI:10.1089/apc.2022.0154 2023
Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study [0.03%]
整合酶抑制剂时代多药疗法及潜在药物间不良相互作用的危险因素：一项前瞻性临床研究
Lutfiye Nilsun Altunal,Dilek Yagcı Caglayık,Ayse Serra Ozel et al.
Lutfiye Nilsun Altunal et al.
People living with human immunodeficiency virus (PLWH), with the availability of modern antiretroviral drugs, have multiple comorbidities, which increase the risk of polypharmacy and potential drug-drug interactions (PDDIs). This is a parti...
Observational Study
AIDS patient care and STDs. 2023 Mar;37(3):138-145. DOI:10.1089/apc.2022.0206 2023
Weight Change When Initiating, Switching to, and Discontinuing Integrase Strand Transfer Inhibitors in People Living with HIV [0.03%]
启动、转换和停止整合酶链转移抑制剂治疗的HIV感染者的体重变化
Warittha Tieosapjaroen,Eric P F Chow,Christopher K Fairley et al.
Warittha Tieosapjaroen et al.
Further investigations into the relationship between integrase strand transfer inhibitors (INSTIs) and weight gain are required, especially whether ceasing INSTI results in weight loss. We evaluated weight changes associated with different ...